ChemPartner PharmaTech Co Ltd
SZSE:300149

Watchlist Manager
ChemPartner PharmaTech Co Ltd Logo
ChemPartner PharmaTech Co Ltd
SZSE:300149
Watchlist
Price: 11.3 CNY -6.38% Market Closed
Market Cap: 5.6B CNY

Intrinsic Value

The intrinsic value of one ChemPartner PharmaTech Co Ltd stock under the Base Case scenario is 8.85 CNY. Compared to the current market price of 11.3 CNY, ChemPartner PharmaTech Co Ltd is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
8.85 CNY
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ChemPartner PharmaTech Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ChemPartner PharmaTech Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ChemPartner PharmaTech Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ChemPartner PharmaTech Co Ltd.

Explain Valuation
Compare ChemPartner PharmaTech Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ChemPartner PharmaTech Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ChemPartner PharmaTech Co Ltd

Current Assets 680.4m
Cash & Short-Term Investments 376.1m
Receivables 278.2m
Other Current Assets 26.1m
Non-Current Assets 1.3B
Long-Term Investments 250.2m
PP&E 645.2m
Intangibles 32.7m
Other Non-Current Assets 372m
Current Liabilities 343.4m
Accounts Payable 50.3m
Accrued Liabilities 32.9m
Short-Term Debt 56.3m
Other Current Liabilities 203.9m
Non-Current Liabilities 399.1m
Long-Term Debt 339.4m
Other Non-Current Liabilities 59.7m
Efficiency

Free Cash Flow Analysis
ChemPartner PharmaTech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ChemPartner PharmaTech Co Ltd

Revenue
1.1B CNY
Cost of Revenue
-774.6m CNY
Gross Profit
293.9m CNY
Operating Expenses
-454.7m CNY
Operating Income
-160.8m CNY
Other Expenses
3.1m CNY
Net Income
-157.7m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

ChemPartner PharmaTech Co Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Operating Margin is Increasing
Sustainable 3Y Average Gross Margin
Gross Margin is Increasing
21/100
Profitability
Score

ChemPartner PharmaTech Co Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ChemPartner PharmaTech Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
69/100
Solvency
Score

ChemPartner PharmaTech Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ChemPartner PharmaTech Co Ltd

There are no price targets for ChemPartner PharmaTech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ChemPartner PharmaTech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ChemPartner PharmaTech Co Ltd stock?

The intrinsic value of one ChemPartner PharmaTech Co Ltd stock under the Base Case scenario is 8.85 CNY.

Is ChemPartner PharmaTech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 11.3 CNY, ChemPartner PharmaTech Co Ltd is Overvalued by 22%.

Back to Top